SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13D/A
(Rule 13d-101)
(Amendment No. 20)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
RULE 13(d)-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13(d)-2(a)
KOOR INDUSTRIES LIMITED
(Name of Issuer)
Ordinary Shares/American Depositary Shares
(Title of Class of Securities)
500 507 108
(CUSIP Number)
Marc A. Berger, Esq.
Davies Ward Phillips & Vineberg LLP
625 Madison Ave, 12th Floor, New York, NY 10022
(212) 308-8866
(Name, Address and Telephone Number
of Person Authorized to Receive Notices and Communications)
July 3, 2006
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check
the following box. |_|
Note: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits. See Rule
13d-7(b) for other parties to whom copies are to be sent.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934, as amended, and the regulations of the Securities and Exchange
Commission promulgated thereunder (the "Exchange Act") or otherwise subject to
the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
--------------------------------------------------------------------------------
CUSIP No. 500 507 108 13D Page 2 of 14
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Claridge Israel LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS**
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES** |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON**
CO
--------------------------------------------------------------------------------
**SEE INSTRUCTIONS BEFORE FILLING OUT!
--------------------------------------------------------------------------------
CUSIP No. 500 507 108 13D Page 3 of 14
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
CBT Holdings LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS**
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES** |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON**
CO
--------------------------------------------------------------------------------
**SEE INSTRUCTIONS BEFORE FILLING OUT!
--------------------------------------------------------------------------------
CUSIP No. 500 507 108 13D Page 4 of 14
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Charles Rosner Bronfman Family Trust
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS**
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES** |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON**
0O
--------------------------------------------------------------------------------
**SEE INSTRUCTIONS BEFORE FILLING OUT!
--------------------------------------------------------------------------------
CUSIP No. 500 507 108 13D Page 5 of 14
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
The Charles Bronfman Trust
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS**
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES** |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON**
OO
--------------------------------------------------------------------------------
**SEE INSTRUCTIONS BEFORE FILLING OUT!
--------------------------------------------------------------------------------
CUSIP No. 500 507 108 13D Page 6 of 14
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
The Charles R. Bronfman Trust
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS**
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES** |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON**
OO
--------------------------------------------------------------------------------
**SEE INSTRUCTIONS BEFORE FILLING OUT!
--------------------------------------------------------------------------------
CUSIP No. 500 507 108 13D Page 7 of 14
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Esarbee Investments Limited
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS**
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES** |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON**
CO
--------------------------------------------------------------------------------
**SEE INSTRUCTIONS BEFORE FILLING OUT!
--------------------------------------------------------------------------------
CUSIP No. 500 507 108 13D Page 8 of 14
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
87215 Canada Ltd.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS**
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES** |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON**
CO
--------------------------------------------------------------------------------
**SEE INSTRUCTIONS BEFORE FILLING OUT!
--------------------------------------------------------------------------------
CUSIP No. 500 507 108 13D Page 9 of 14
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Anfield Limited
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS**
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
672,174*
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 672,174*
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
672,174*
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES** |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.1%*
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON**
CO
--------------------------------------------------------------------------------
**SEE INSTRUCTIONS BEFORE FILLING OUT!
* All Ordinary Shares beneficially owned by the Reporting Person are subject to
the "Anfield Agreements referred to in Items 4, 6 and 7. The percentage set
forth in line 13 above is based on 16,464,964 Ordinary Shares outstanding as of
July 2, 2006 (excluding 15,799 Ordinary Shares owned by a wholly owned
subsidiary of the Issuer), as the Issuer advised the Reporting Persons.
The following constitutes Amendment No. 20 ("Amendment No. 20") to the Schedule
13D dated October 22, 1997, as amended by Amendment Nos. 1 - 19 (collectively,
as amended, the "Original Schedule 13D"). This Amendment No. 20 amends the
Original Schedule 13D as specifically set forth herein.
Item 2: Identity and Background.
The first paragraph of Item 2 is replaced with the following text:
This Amendment No. 20 is being filed by Esarbee Investments Limited, a Canadian
corporation ("Esarbee"), Claridge Israel LLC, a Delaware limited liability
company ("Claridge"), The Charles Bronfman Trust, a Delaware trust ("CBT"), CBT
Holdings LLC, a Delaware limited liability company wholly owned by CBT ("CBT
Holdings"), the Charles Rosner Bronfman Family Trust, a trust organized under
the laws of the Province of Quebec and the indirect owner of Esarbee ("CRBFT"),
The Charles R. Bronfman Trust ("CR.BT") and Anfield Limited ("Anfield"). All of
such entities are already Reporting Persons. This Amendment No. 20 is also being
filed by 87215 Canada Ltd. ("87215"), which is included among the "Reporting
Persons" referred to in this Amendment No. 20.
With respect to 87215, the following information is inserted in the appropriate
subsection within Item 2:
(b) 87215 has a business address at c/o Bennett Jones LLP, 4500 Bankers Hall
East, 855 - 2nd Street S.W., Calgary, Alberta T2P 4K7 Canada. Schedule I to this
Amendment No. 20 contains the name, business address, present principal
occupation and citizenship of each of the directors and executive officers of
87215 (the "Schedule I Persons").
(c) The principal activities of 87215 consist of the acquisition, ownership,
disposition and reinvestment of investment assets and related business
activities.
(d) During the past five years, neither 87215 nor, to the best of its knowledge,
any of the Schedule I Persons have been convicted in a criminal proceeding.
(e) During the past five years, neither 87215 nor, to the best of its knowledge,
any of the Schedule I Persons have been a party to any civil proceeding as a
result of which it has been subject to a judgment, decree or final order
enjoining future violations of, or prohibiting or mandating activities subject
to, federal or state securities laws, or finding any violation with respect to
such laws.
Item 4. Purpose of Transaction.
Item 4 in the Original Schedule 13D is hereby amended by inserting the
following text at the end thereof:
The closing of the purchase and sale of the Ordinary Shares under the
Share Purchase Agreement dated May 1, 2006 (the "Share Purchase Agreement")
occurred on July 3, 2006 (the "closing"), such that Purchaser completed the
purchase of an aggregate of 5,081,033 Ordinary
Shares, representing approximately 30.9% of the Issuer's outstanding share
capital, for an aggregate purchase price of US$393,780,057, or US$77.50 per
Ordinary Share.
In connection with the closing, the parties to the Share Purchase
Agreement amended it by way of entering into an Amendment Agreement, dated July
3, 2006 (the "Amendment Agreement"). The Amendment Agreement only amended the
agreements between Anfield and the Purchaser, and (other than the first sentence
of the last paragraph of this Item 4) the balance of the disclosure in this Item
4 relates to Anfield only. Pursuant to the Amendment Agreement:
(1) The number of Ordinary Shares acquired by Purchaser at the
closing was reduced by 672,174 Ordinary Shares (from 5,753,207 Ordinary Shares
to 5,081,033), representing approximately 4.1% of the Issuer's outstanding share
capital. These 672,174 Ordinary Shares (the "Anfield Shares") were and remain
held by Anfield Limited, one of the sellers under the Share Purchase Agreement,
and did not include any of the 90,000 Ordinary Shares that were beneficially
owned by 87215, which is the entity referred to in the Share Purchase Agreement
as the "related entity" on behalf of which Anfield was acting;
(2) Anfield was granted a put option, exercisable during the period
commencing on December 1, 2006 and ending on December 24, 2006, to sell the
Anfield Shares to Purchaser on December 28, 2006, for an aggregate consideration
of NIS 235,806,912 (equating to approximately US$53,109,665), or approximately
NIS 350.81 per Ordinary Share (equating to approximately US$79), subject to
adjustments for distributions made by the Issuer and linked to the Israeli
Consumer Price Index; and
(3) Anfield received at the closing an interest-bearing loan from
Purchaser in the amount of NIS 231,295,073 (equating to approximately
US$52,093,485), a portion of the proceeds of which are intended to secure the
release of security interests that exist over the Anfield Shares. The loan,
which matures in December 2006, was granted pursuant to the terms of a Loan
Agreement, dated July 3, 2006, by and between Purchaser, as lender, and Anfield,
as borrower (the "Loan Agreement") and is secured by (i) a first ranking fixed
charge over the Anfield Shares in favor of Purchaser pursuant to the terms of a
Debenture by and between Purchaser and Anfield of even date therewith (the
"Debenture") and (ii) Anfield's depositing the Anfield Shares in escrow.
In connection with the Closing, seven members of the Board of Directors of
the Issuer resigned and five members, designated by Purchaser, were appointed to
the Board of Directors of the Issuer. In addition, Purchaser and Anfield entered
into a Guarantee Facility Agreement, dated July 3, 2006, whereby Purchaser
undertook to provide a US$10,000,000 guaranty to a bank in order to assist
Anfield to obtain a credit facility from one of the four major Israeli banks in
an amount of US$40,000,000 for the sole purpose of purchasing publicly-traded
securities of companies at Anfield's discretion, subject to the terms and
conditions set forth therein.
The foregoing description of the Amendment Agreement, Loan Agreement and
Debenture (collectively, the "Anfield Agreements") does not purport to be
complete and is subject to, and qualified in its entirety by reference to, the
provisions of the Amendment Agreement, Loan Agreement and Debenture filed as
Exhibits 99.1, 99. 2 and 99.3 hereto, respectively.
The above-described transactions do not evidence any change in the purpose
of the Reporting Persons that sold their Ordinary Shares. The Anfield Agreements
do not reflect a change in Anfield's purpose in entering into the Share Purchase
Agreement, but reflect Anfield's
willingness to delay or (if Anfield chooses not to exercise the above-described
put agreement) forego and terminate Anfield's right and obligation to sell its
Ordinary Shares in consideration for the various agreements of the Purchaser set
forth in the Anfield Agreements and the Guaranty Facility Agreement. Based upon
market conditions existing prior to the expiration of the put option, Anfield
will take such actions with respect to the put option as it deems appropriate.
Item 5. Interest in Securities of the Issuer.
(a) Section (a) of Item 5 of the Original Schedule 13D is amended and
restated in its entirety as follows:
Percentages below are based on 16,464,964 Ordinary Shares outstanding as
of July 2, 2006 (excluding 15,799 Ordinary Shares owned by a wholly owned
subsidiary of the Issuer), as the Issuer advised the Reporting Persons.
Each of CBT Holdings, Claridge, 87215, CBT, Esarbee, CRBFT and CR.BT now
beneficially own zero (-0-) Ordinary Shares.
Anfield directly owns an aggregate of 672,174 Ordinary Shares,
representing 4.1% of the issued and outstanding Ordinary Shares.
(b) Section (b) of Item 5 of the Original Schedule 13D is hereby amended
and restated in its entirety as follows:
Section 5(b) is no longer applicable to CBT Holdings, Claridge, 87215,
CBT, Esarbee, CRBFT and CR.BT, none of which beneficially own any Ordinary
Shares after the closing.
Anfield has sole voting right and rights to dispose of its 672,174
Ordinary Shares. All of these Ordinary Shares are subject to the Anfield
Agreements.
(c) During the last sixty days there have been no transactions in the
Ordinary Shares effected by the Reporting Persons, nor, to the best of their
knowledge, any of their respective Schedule I Persons.
(d) N/a
(e) Each of the Reporting Persons has ceased to be the beneficial owner of
more than five percent of the Ordinary Shares (whether in the form of Ordinary
Shares or ADRs) and, accordingly, is no longer a "reporting person" with respect
to such securities of the Issuer.
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to
Securities of Issuer.
Other than customary surviving obligations for breaches of representations
and warranties under the Share Purchase Agreement, as amended, the selling
Reporting Persons are no longer parties to any contracts or arrangements with
respect to the Issuer's Ordinary Shares. Anfield is not a party to any contracts
or arrangements with respect to the securities of Issuer
other than the Anfield Agreements described in Item 4 above, which description
is incorporated herein by reference.
Item 7. Material to be Filed as Exhibits.
Exhibit 99.1. Amendment Agreement (incorporated by reference to
Exhibit 1 to Amendment No. 2 on Schedule 13D/A (filed on
July 10, 2006) to the Statement on Schedule 13D in
respect of the Ordinary Shares of the Issuer initially
filed by IDB Development Corporation Ltd., IDB Holding
Corporation Ltd., Mr. Nochi Dankner, Mrs. Shelly
Bergman, Mrs. Ruth Manor and Mr. Avraham Livnat, with
the Securities and Exchange Commission on June 6, 2005,
hereinafter "Amendment No. 2 to the Purchaser's Schedule
13D").
Exhibit 99.2 Loan Agreement between Anfield, as borrower, and the
Purchaser, as lender (incorporated by reference to
Exhibit 2 to Amendment No. 2 to the Purchaser's Schedule
13D).
Exhibit 99.3 Debenture from Anfield, as pledgor, in favor of the
Purchaser (incorporated by reference to Exhibit 3 to
Amendment No. 2 to the Purchaser's Schedule 13D).
* * *
SIGNATURE
After reasonable inquiry and to the best of the knowledge and belief of
the undersigned, the undersigned hereby certifies that the information contained
in this statement is true, complete and correct.
Dated: July 6, 2006
CBT HOLDINGS LLC CLARIDGE ISRAEL LLC
By: /s/ Bruce I. Judelson By: /s/ Bruce I. Judelson
----------------------------------- ---------------------------------
Name: Bruce I. Judelson Name: Bruce I. Judelson
Title: Authorized Signatory Title: Authorized Signatory
ESARBEE INVESTMENTS LIMITED CHARLES ROSNER BRONFMAN
FAMILY TRUST
By: /s/ Oded Tal By: /s/ Oded Tal
----------------------------------- ---------------------------------
Name: Oded Tal Name: Oded Tal
Title: Vice President, Investments Title: Authorized Representative
ANFIELD LIMITED THE CHARLES BRONFMAN TRUST
By: /s/ Alan Sacks By: /s/ Jay H. Rubinstein
----------------------------------- ---------------------------------
Name: Alan Sacks Name: Jay H. Rubinstein
Title: Director Title: Trustee
87215 CANADA LTD. THE CHARLES R. BRONFMAN TRUST
By: /s/ Alan Sacks By: /s/ Oded Tal
----------------------------------- ---------------------------------
Name: Alan Sacks Name: Oded Tal
Title: Authorized Signatory Title: Authorized Signatory
SCHEDULE I
TO SCHEDULE 13D
Information with Respect to
Shareholders, Directors and Executive Officers of 87215 Canada Ltd. ("87215")
Controlling Present Business Present Principal
Shareholder Address Occupation Citizenship
----------- ------- ---------- -----------
3096475 4500 Bankers Hall East Investment holdings Canada
Canada Inc.* 855 - 2nd Street S.W.
Calgary, Alberta
T2P 4K7 Canada
Board of Directors of Reporting
Person (87215) and above-named
controlling shareholder
Senator E. Leo c/o Bennett Jones LLP Private Investor/ Canada
Kolber* 4500 Bankers Hall East Senator (retired)
855 - 2nd Street S.W.
Calgary, Alberta
T2P 4K7 Canada
Zeno Santache c/o Claridge Inc. Chief Financial Canada
1170 Peel Street Officer,
Montreal, Quebec Claridge Inc.
Canada
Executive Officers of Reporting
Person (87215) and above-named
controlling shareholder
Senator E. Leo As above
Kolber
Zeno Santache As above
Richard P. c/o Claridge Inc. Consultant Canada
Doyle 1170 Peel Street
Montreal, Quebec
Canada
Michel c/o Claridge Inc. Consultant Canada
Boucher** 1170 Peel Street
Montreal, Quebec
Canada
Glenn c/o Claridge Inc. Controller, Canada
Hamilton- 1170 Peel Street Claridge Inc.
Browne Montreal, Quebec
Canada
* Senator E. Leo Kolber is the sole shareholder of 3096475 Canada Inc.
** Executive Officer of 87215 only